383 related articles for article (PubMed ID: 25461367)
21. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.
Bahçeci M; Ulug U; Ben-Shlomo I; Erden HF; Akman MA
J Reprod Med; 2005 Feb; 50(2):84-90. PubMed ID: 15755044
[TBL] [Abstract][Full Text] [Related]
22. A novel modified ultra-long agonist protocol improves the outcome of high body mass index women with polycystic ovary syndrome undergoing IVF/ICSI.
Tu J; Lin G; Lu C; Gong F
Gynecol Endocrinol; 2014 Mar; 30(3):209-12. PubMed ID: 24351071
[TBL] [Abstract][Full Text] [Related]
23. Successive and cyclic oral contraceptive pill pretreatment improves IVF/ICSI outcomes of PCOS patients and ameliorates hyperandrogenism and antral follicle excess.
Pan JX; Liu Y; Ke ZH; Zhou CL; Meng Q; Ding GL; Xu GF; Sheng JZ; Huang HF
Gynecol Endocrinol; 2015 Apr; 31(4):332-6. PubMed ID: 25558892
[TBL] [Abstract][Full Text] [Related]
24. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
[TBL] [Abstract][Full Text] [Related]
25. [Effect of hyperandrogenism on pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer].
Jiang LL; Pan P; Jiao XD; Qiu Q; Li Y; Zhang QX
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1042-1048. PubMed ID: 37032154
[No Abstract] [Full Text] [Related]
26. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
27. Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.
Lin H; Li Y; Li L; Wang W; Yang D; Zhang Q
PLoS One; 2014; 9(3):e91796. PubMed ID: 24642641
[TBL] [Abstract][Full Text] [Related]
28. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
29. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.
Okohue JE; Onuh SO; Ikimalo JI
Niger J Clin Pract; 2013; 16(2):207-10. PubMed ID: 23563463
[TBL] [Abstract][Full Text] [Related]
30. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
[TBL] [Abstract][Full Text] [Related]
31. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis.
Xiao J; Chen S; Zhang C; Chang S
Gynecol Endocrinol; 2013 Mar; 29(3):187-91. PubMed ID: 23194095
[TBL] [Abstract][Full Text] [Related]
33. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
34. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
[TBL] [Abstract][Full Text] [Related]
35. A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial.
Jacob SL; Brewer C; Tang T; Picton HM; Barth JH; Balen AH
Hum Reprod; 2016 Dec; 31(12):2756-2764. PubMed ID: 27816925
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of pretreatment with Cetrotide in an antagonist protocol for patients with PCOS undergoing IVF/ICSI cycles: a randomized clinical trial.
Eftekhar M; Bagheri RB; Neghab N; Hosseinisadat R
JBRA Assist Reprod; 2018 Sep; 22(3):238-243. PubMed ID: 29969209
[TBL] [Abstract][Full Text] [Related]
37. Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome.
Şükür YE; Özmen B; Özdemir ED; Seval MM; Kalafat E; Sönmezer M; Berker B; Aytaç R; Atabekoğlu CS
Reprod Biomed Online; 2017 Jan; 34(1):5-10. PubMed ID: 27771155
[TBL] [Abstract][Full Text] [Related]
38. Steroids pretreatment in assisted reproduction cycles.
Sobotka V; Streda R; Mardesic T; Tosner J; Heracek J
J Steroid Biochem Mol Biol; 2014 Jan; 139():114-21. PubMed ID: 23685395
[TBL] [Abstract][Full Text] [Related]
39. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
40. Endometrial preparation for vitrified-warmed embryo transfer with or without GnRH-agonist pre-treatment in patients with polycystic ovary syndrome: a randomized controlled trial.
Salemi S; Yahyaei A; Vesali S; Ghaffari F
Reprod Biomed Online; 2021 Sep; 43(3):446-452. PubMed ID: 34340936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
